Form 4: MiNK Therapeutics Director Ulf Wiinberg Acquires Shares Through Restricted Stock Unit Grant

MiNK Therapeutics Director Ulf Wiinberg has acquired 1,953 shares of common stock through a restricted stock unit grant, received in lieu of cash compensation for board and committee services.

Summary

• Ulf Wiinberg, a Director of MiNK Therapeutics, Inc. (INKT), acquired 1,953 shares of common stock on June 2, 2025.
• The shares were granted as Restricted Stock Units (RSUs) at a price of $7.17 per share, in lieu of cash retainers for his board and committee compensation.
• These RSUs are scheduled to vest one month from the grant date.
• Following this transaction, Mr. Wiinberg directly beneficially owns 17,960 shares of common stock.
• Additionally, he indirectly beneficially owns 27,830 shares held in an irrevocable trust for the benefit of his family.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as a director is increasing their equity stake in the company, aligning their interests with shareholders. This is a standard compensation mechanism (RSU grant in lieu of cash) rather than an open market purchase, which tempers the positive signal slightly.

Positives

• Director Ulf Wiinberg acquired 1,953 shares of common stock, indicating continued alignment of interests with shareholders.
• The grant of Restricted Stock Units (RSUs) in lieu of cash compensation suggests a commitment to equity-based incentives for board members, conserving cash for the company.

Future Outlook

The Restricted Stock Units granted to Director Ulf Wiinberg are expected to vest one month from the grant date of June 2, 2025.

Industry Context

This Form 4 filing reflects a routine insider transaction where a director receives equity compensation, a common practice across industries to align management incentives with shareholder interests. The specific grant of Restricted Stock Units (RSUs) in lieu of cash is a prevalent method for compensating board members in the biotechnology and pharmaceutical sectors, including companies like MiNK Therapeutics, Inc., to conserve cash and promote long-term equity ownership.

Related Party Transactions

• Shares are held indirectly in an irrevocable trust for the benefit of Mr. Wiinberg's family, which constitutes a related party beneficial ownership.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders due to equity compensation.
• Management/Board: Reinforces equity-based compensation practices for board members.

Next Steps

• The granted Restricted Stock Units (RSUs) are expected to vest one month from the grant date of June 2, 2025.

Key Dates

Keywords

MiNK Therapeutics, INKT, Ulf Wiinberg, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership